News
Jubilant Pharmova consolidated net profit declines 22.27% in the March 2026 quarter
22-May-2026 | 17:31
Sales rise 18.60% to Rs 2272.20 crore
Net profit of Jubilant Pharmova declined 22.27% to Rs 119.40 crore in the quarter ended March 2026 as against Rs 153.60 crore during the previous quarter ended March 2025. Sales rose 18.60% to Rs 2272.20 crore in the quarter ended March 2026 as against Rs 1915.80 crore during the previous quarter ended March 2025.
For the full year,net profit declined 52.53% to Rs 398.50 crore in the year ended March 2026 as against Rs 839.40 crore during the previous year ended March 2025. Sales rose 14.36% to Rs 8225.00 crore in the year ended March 2026 as against Rs 7192.10 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 2272.20 | 1915.80 | 19 | 8225.00 | 7192.10 | 14 |
| OPM % | 14.93 | 18.02 | - | 15.31 | 16.31 | - |
| PBDT | 306.50 | 304.50 | 1 | 1113.70 | 989.70 | 13 |
| PBT | 189.70 | 209.30 | -9 | 673.30 | 621.10 | 8 |
| NP | 119.40 | 153.60 | -22 | 398.50 | 839.40 | -53 |
Powered by Capital Market - Live News
